FDA Inspection 1036694 — Zhejiang Chiral Medicine Chemicals Co., Ltd.
The FDA completed an inspection of Zhejiang Chiral Medicine Chemicals Co., Ltd. on October 13, 2017 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 13, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)